Abattis Bioceuticals Corp. (ATTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Aug 19, 2025, 4:00 PM EDT
Abattis Bioceuticals Company Description
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada.
The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets.
It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry.
The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012.
Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Abattis Bioceuticals Corp.
| Country | Canada |
| Founded | 1997 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
Contact Details
Address: 625 Howe Street Vancouver, British Columbia V6C 2M6 Canada | |
| Phone | 808 650 3007 |
| Website | abattis.com |
Stock Details
| Ticker Symbol | ATTBF |
| Exchange | OTCMKTS |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| ISIN Number | CA00258G1037 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Francesco Paolini | Chief Financial Officer and Director |
| Patrick Mitchell | Chief Operating Officer and Director |
| Shawn Balaghi | Head of Corporate Development |
| Jim Carter | Head of Mergers and Acquisitions Advisory |
| Christopher P. Cherry C.A., CPA, CGA | Corporate Comptroller |
| Nicole Breitinger | Corporate Secretary |